- Home
- RGNX vs ACB Comparison
RGNX vs ACB Comparison
Compare RGNX & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- ACB
- Stock Information
- Founded
- RGNX 2008
- ACB 2013
- Country
- RGNX United States
- ACB Canada
- Employees
- RGNX N/A
- ACB N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- ACB Pharmaceuticals and Biotechnology
- Sector
- RGNX Health Care
- ACB Health Care
- Exchange
- RGNX Nasdaq
- ACB Nasdaq
- Market Cap
- RGNX 387.0M
- ACB 313.9M
- IPO Year
- RGNX 2015
- ACB N/A
- Fundamental
- Price
- RGNX $8.54
- ACB $3.92
- Analyst Decision
- RGNX Strong Buy
- ACB Hold
- Analyst Count
- RGNX 8
- ACB 1
- Target Price
- RGNX $31.75
- ACB N/A
- AVG Volume (30 Days)
- RGNX 1.1M
- ACB 1.5M
- Earning Date
- RGNX 07-31-2025
- ACB 06-18-2025
- Dividend Yield
- RGNX N/A
- ACB N/A
- EPS Growth
- RGNX N/A
- ACB N/A
- EPS
- RGNX N/A
- ACB 0.03
- Revenue
- RGNX $156,718,000.00
- ACB $238,837,444.00
- Revenue This Year
- RGNX $327.08
- ACB $12.22
- Revenue Next Year
- RGNX N/A
- ACB $7.36
- P/E Ratio
- RGNX N/A
- ACB $136.22
- Revenue Growth
- RGNX 80.70
- ACB 27.32
- 52 Week Low
- RGNX $5.04
- ACB $3.42
- 52 Week High
- RGNX $15.36
- ACB $7.20
- Technical
- Relative Strength Index (RSI)
- RGNX 46.38
- ACB 30.52
- Support Level
- RGNX $7.82
- ACB $3.87
- Resistance Level
- RGNX $10.64
- ACB $6.21
- Average True Range (ATR)
- RGNX 0.82
- ACB 0.29
- MACD
- RGNX -0.19
- ACB -0.26
- Stochastic Oscillator
- RGNX 25.57
- ACB 2.31
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About ACB Aurora Cannabis Inc.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.